Picture of virus under microscope

Research under the microscope...

The Strathprints institutional repository is a digital archive of University of Strathclyde research outputs.

Strathprints serves world leading Open Access research by the University of Strathclyde, including research by the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), where research centres such as the Industrial Biotechnology Innovation Centre (IBioIC), the Cancer Research UK Formulation Unit, SeaBioTech and the Centre for Biophotonics are based.

Explore SIPBS research

Vaccination against toxoplasmosis: current status and future prospects

Schaap, D. and Vermeulen, A.N. and Roberts, C.W. and Alexander, J. (2007) Vaccination against toxoplasmosis: current status and future prospects. In: Toxoplasma gondii the Model Apicomplexan - Perspective and Methods. Academic Press, pp. 721-760. ISBN 0123695422

Full text not available in this repository. (Request a copy from the Strathclyde author)

Abstract

Chapter focusing on vaccination against toxoplasmosis. Toxoplasmosis is caused by a one-celled protozoan parasite known as Toxoplasma gondii. In the United States, it is estimated that approximately 30% of cats, the primary carriers, have been infected by T. gondii. Most humans contract toxoplasmosis by eating cyst-contaminated raw or undercooked meat, vegetables, or milk products or when they come into contact with the T. gondii eggs from cat feaces while cleaning a cat's litterbox, gardening, or playing in a sandbox.